You are here

MNK-795

Mallinckrodt's extended-release pain drug meets main goal of study

Reuters

Fri, 09/6/13 - 10:25 am

FDA Grants Priority Review To New Drug Application For MNK-795 Submitted By Depomed Licensee Mallinckrodt

Yahoo

Mon, 07/29/13 - 10:50 am